|
Back to Home » January 2022 News » Cytovation raises $20 million in Series A financing round to advance clinical development of CyPep-1, a first-in-class targeted tumor membrane immunotherapy |
Cytovation raises $20 million in Series A financing round to advance clinical development of CyPep-1, a first-in-class targeted tumor membrane immunotherapy |
January 25, 2022
BERGEN, Norway, Jan. 25, 2022 /PRNewswire/ -- Cytovation AS, a clinical stage immune-oncology company focused on the development of its first-in-class targeted tumor membrane immunotherapy, announces the successful closing of its Series A financing round, raising a total of NOK 180...
Source URL: https://www.prnewswire.com:443/news-releases/cytovation-raises-20-million-in-series-a-financing-round-to-advance-clinical-development-of-cypep-1-a-first-in-class-targeted-tumor-membrane-immunotherapy-301466434.html
|
|
|
|
